CAR T Cell Therapy

News

NICE recommends first CAR-T cell therapy on NHS in England

Gilead Sciences and Kite, a Gilead company, have announced that the National Institute for Health and Care Excellence (NICE) has recommended Yescarta (axicabtagene ciloleucel; axi-cel) for

News

Autolus announces primary endpoint met in FELIX trial, price...

Autolus Therapeutic Plc.

Oncology

Communication problems holding back new cancer treatments

Cancer immunotherapy is revolutionising oncology – but the Havas Lynx Group’s chief medical officer Vernon Bainton argues that the incredible progress is creating a new

Partner Content

Invitation from Chair of this year’s Immuno-Oncology Confere...

Invitation from Chair of Immuno-Oncology Conference

NICE recommends first CAR-T cell therapy on NHS in England

Autolus announces primary endpoint met in FELIX trial, price...

Communication problems holding back new cancer treatments

Invitation from Chair of this year’s Immuno-Oncology Confere...

NHS staff 'feel unprepared for digital transformation'

How to meet your physicians where they are online

CAR T Cell Therapy

Editor's Picks